Zhejiang Hisun Biomaterials Stock Total Debt
| 688203 Stock | 10.49 0.21 2.04% |
Zhejiang HISUN Biomaterials fundamentals help investors to digest information that contributes to Zhejiang HISUN's financial success or failures. It also enables traders to predict the movement of Zhejiang Stock. The fundamental analysis module provides a way to measure Zhejiang HISUN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zhejiang HISUN stock.
Zhejiang | Total Debt |
Zhejiang HISUN Biomaterials Company Total Debt Analysis
Zhejiang HISUN's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Zhejiang HISUN Total Debt | 179.55 M |
Most of Zhejiang HISUN's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhejiang HISUN Biomaterials is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Zhejiang Net Debt
Net Debt |
|
Based on the latest financial disclosure, Zhejiang HISUN Biomaterials has a Total Debt of 179.55 M. This is 91.31% lower than that of the Chemicals sector and 96.25% lower than that of the Materials industry. The total debt for all China stocks is 96.62% higher than that of the company.
Zhejiang Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhejiang HISUN's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhejiang HISUN could also be used in its relative valuation, which is a method of valuing Zhejiang HISUN by comparing valuation metrics of similar companies.Zhejiang HISUN is currently under evaluation in total debt category among its peers.
Zhejiang Fundamentals
| Return On Equity | 0.0267 | |||
| Return On Asset | 0.012 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.8 B | |||
| Shares Outstanding | 202.68 M | |||
| Shares Owned By Insiders | 70.21 % | |||
| Shares Owned By Institutions | 1.15 % | |||
| Price To Book | 1.42 X | |||
| Price To Sales | 2.59 X | |||
| Revenue | 753.32 M | |||
| Gross Profit | 80.89 M | |||
| EBITDA | 100.72 M | |||
| Net Income | 43.55 M | |||
| Total Debt | 179.55 M | |||
| Book Value Per Share | 7.39 X | |||
| Cash Flow From Operations | 163.03 M | |||
| Earnings Per Share | 0.20 X | |||
| Number Of Employees | 383 | |||
| Beta | 0.66 | |||
| Market Capitalization | 2.13 B | |||
| Total Asset | 2.05 B | |||
| Retained Earnings | 65.57 M | |||
| Working Capital | 627.83 M | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.05 B | |||
| Last Dividend Paid | 0.08 |
About Zhejiang HISUN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhejiang HISUN Biomaterials's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhejiang HISUN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhejiang HISUN Biomaterials based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Zhejiang Stock
Zhejiang HISUN financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang HISUN security.